Raizman M B, Austen K F, Katz H R
Department of Medicine, Harvard Medical School, Boston, MA.
J Immunol. 1990 Sep 1;145(5):1463-8.
The synthesis and intracellular expression of glycosphingolipids by mouse serosal mast cells (SMC) have been characterized by radiolabeling and TLC and by immunodetection in situ. Chromatographic analysis of purified glycosphingolipids from SMC intrinsically labeled with [14C]galactose and [14C]glucosamine hydrochloride revealed the predominant synthesis of only the simplest neutral glycosphingolipid and ganglioside, glucosylceramide and ganglioside GM3, respectively. Intracellular indirect immunofluorescence staining of permeabilized SMC demonstrated the absence of the more complex neutral glycosphingolipids lactosylceramide, globotriosylceramide, globotetraosylceramide, and globopentaosylceramide, the absence of ganglioside GM1, and the presence of ganglioside GM3. By contrast, permeabilized mouse IL-3-dependent bone marrow culture-derived mast cells (BMMC) and mast cells recovered after 21 days of coculture of BMMC with mouse 3T3 fibroblasts expressed lactosylceramide, globotriosylceramide, globotetraosylceramide, ganglioside GM1, and ganglioside GM3, but not globopentaosylceramide intracellularly as determined by immunofluorescence. The findings indicate a loss of biosynthetic capacity and epitope maintenance for glycosphingolipids with in vivo differentiation of SMC from IL-3-dependent BMMC progenitors. Thus, although mast cells derived after coculture of these progenitors for 21 days with fibroblasts assume multiple SMC-like properties in terms of their histochemical staining and their secretory granule proteoglycan and neutral protease constituents, they do not lose the ability to express complex glycosphingolipids. The finding that glycosphingolipid composition does not change coordinately with other secretory granule markers defines a new stage of mouse mast cell development between the BMMC and SMC and provides evidence that mast cell development is more complex than previously appreciated.
通过放射性标记、薄层层析(TLC)以及原位免疫检测,对小鼠浆膜肥大细胞(SMC)中糖鞘脂的合成及细胞内表达进行了表征。对用[14C]半乳糖和盐酸[14C]葡萄糖胺进行内在标记的SMC纯化糖鞘脂进行色谱分析,结果显示分别仅主要合成了最简单的中性糖鞘脂和神经节苷脂,即葡萄糖神经酰胺和神经节苷脂GM3。对透化的SMC进行细胞内间接免疫荧光染色表明,不存在更复杂的中性糖鞘脂乳糖神经酰胺、球三糖神经酰胺、球四糖神经酰胺和球五糖神经酰胺,不存在神经节苷脂GM1,而存在神经节苷脂GM3。相比之下,透化的小鼠白细胞介素-3依赖性骨髓培养来源的肥大细胞(BMMC)以及BMMC与小鼠3T3成纤维细胞共培养21天后回收的肥大细胞,通过免疫荧光测定,细胞内表达乳糖神经酰胺、球三糖神经酰胺、球四糖神经酰胺、神经节苷脂GM1和神经节苷脂GM,但不表达球五糖神经酰胺。这些发现表明,随着SMC从白细胞介素-3依赖性BMMC祖细胞体内分化,其糖鞘脂的生物合成能力和表位维持能力丧失。因此,尽管这些祖细胞与成纤维细胞共培养21天后产生的肥大细胞在组织化学染色、分泌颗粒蛋白聚糖和中性蛋白酶成分方面具有多种类似SMC的特性,但它们并未丧失表达复杂糖鞘脂的能力。糖鞘脂组成与其他分泌颗粒标志物不同步变化这一发现,定义了小鼠肥大细胞在BMMC和SMC之间发育的一个新阶段,并提供了证据表明肥大细胞发育比之前所认识的更为复杂。